In this interview, Technology Networks spoke with Dr. Lena Jonsson, product strategy manager at Cytiva, to explore the ...

Additionally, in the framework of a licensing agreement and a collaborative endeavor to support innovative research, Debiopharm and Oncodesign Services will present promising new data illustrating how ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

Antibody-drug conjugates are a significant evolution in drug development landscape: Dr. Kenneth Barr: Nandita Vijayasimha, Bengaluru Saturday, April 12, 2025, 08:00 Hrs [IST] Anti ...

你发现没，随着医学科技的发展，我们对抗癌症的方式也在不断进化。抗体偶联药物（Antibody-Drug Conjugates, ADC）作为近年来兴起的一种创新性癌症疗法，正逐渐改变着肿瘤治疗的格局。那么，这种新型疗法是如何工作的呢？它又是如何从第一代发展到第三代的呢？今天就让我们一起来扒一扒。

那么，BL-M09D1的研发能否真正改变晚期实体瘤的治疗现状？根据科学研究表明，抗体-药物结合物的精准性和高效性可能会给许多患者提供更多的选择。这种新型治疗不仅能够打破传统药物的局限，还在于它具有个性化的治疗潜力。患者在不同的病理背景和基因特征条件下，能获得定制化的治疗方案，从而提高治疗成功的几率。

Acepodia (6976: TT) today announced the presentation of new preclinical data highlighting its proprietary dual-payload antibody-drug conjugate (AD2C) for hepatocellular carcinoma (HCC). The data will ...

Gilead's Trodelvy and Merck's Keytruda improved progression-free survival in PD-L1+ metastatic TNBC in a Phase 3 trial with ...

Vantage Market Research report examines the Antibody Drug Conjugates (ADCs) market, forecasting trends and dynamics from 2025 to 2035. The report highlights the significance of ADCs in modern oncology ...

CSPC PHARMA (01093.HK) announced that the Investigational New Drug (IND) application for SYS6041 (Antibody-Drug Conjugate) ...

The data could help the Enhertu regimen overtake a drug combination that’s been used as the initial treatment for ...